92 related articles for article (PubMed ID: 21924712)
1. [Castleman's disease, HIV and rituximab].
Valencia ME; López V; Corcuera MT; Del Val D
Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
[No Abstract] [Full Text] [Related]
2. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Castleman's disease & HIV infection.
Cotter A; Lambert J; O'Gorman P
Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
[TBL] [Abstract][Full Text] [Related]
4. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
5. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
[No Abstract] [Full Text] [Related]
6. Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
Buchler T; Dubash S; Lee V; Chilton D; Cartledge J; Isaacson P; Tedder RS; Lee SM
AIDS; 2008 Aug; 22(13):1685-7. PubMed ID: 18670234
[No Abstract] [Full Text] [Related]
7. Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.
Patier de la Peña JL; González-García A; Prieto Pareja E; Norman FF; Rojas Marcos J; Benito Paniagua D
Rev Clin Esp (Barc); 2014 Mar; 214(2):e15-7. PubMed ID: 24365755
[No Abstract] [Full Text] [Related]
8. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
Nord JA; Karter D
Int J STD AIDS; 2003 Jan; 14(1):61-2. PubMed ID: 12590797
[TBL] [Abstract][Full Text] [Related]
9. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
Dupin N; Krivine A; Calvez V; Gorin I; Franck N; Escande JP
AIDS; 1997 Sep; 11(11):1400-1. PubMed ID: 9302455
[No Abstract] [Full Text] [Related]
10. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
[TBL] [Abstract][Full Text] [Related]
11. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
[TBL] [Abstract][Full Text] [Related]
12. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.
Barbarov I; Koren-Michowitz M; Schiby G; Portnoy O; Livingstone D; Segal G
Isr Med Assoc J; 2015 Apr; 17(4):253-5. PubMed ID: 26040056
[No Abstract] [Full Text] [Related]
13. Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
Jain P; Verstovsek S; Loghavi S; Jorgensen JL; Patel KP; Estrov Z; Fayad L; Pemmaraju N
Am J Hematol; 2015 Nov; 90(11):1091-2. PubMed ID: 25808231
[No Abstract] [Full Text] [Related]
14. HIV-associated Castleman's disease: from case reports to evidence.
Bazeos A; Powles T; Stebbing J
J HIV Ther; 2007 Sep; 12(3):61-2. PubMed ID: 17962792
[No Abstract] [Full Text] [Related]
15. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
[TBL] [Abstract][Full Text] [Related]
16. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
Bestawros A; Michel R; Séguin C; Routy JP
Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
[TBL] [Abstract][Full Text] [Related]
17. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
Peker D; Martinez AE; Schwartz MA; Cusnir M
Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
[No Abstract] [Full Text] [Related]
18. [Thoracic manifestations of Castleman's disease].
Dégot T; Métivier A-; Casnedi S; Chenard M-; Kessler R
Rev Pneumol Clin; 2009 Apr; 65(2):101-7. PubMed ID: 19375050
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.
Kumari P; Schechter GP; Saini N; Benator DA
Clin Infect Dis; 2000 Aug; 31(2):602-4. PubMed ID: 10987728
[TBL] [Abstract][Full Text] [Related]
20. Rituximab and thalidomide combination therapy for Castleman disease.
Ramasamy K; Gandhi S; Tenant-Flowers M; Ceesay M; Corderoy S; Marcus R; Schey S
Br J Haematol; 2012 Aug; 158(3):421-3. PubMed ID: 22583139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
